Overview

Safety and Efficacy of SH T00660AA in Treatment of Endometriosis

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate safety and efficacy of SH T00660AA for the treatment of endometriosis
Phase:
Phase 3
Details
Lead Sponsor:
Bayer